The global population health management market size was USD 31 billion in 2023, calculated at USD 36.49 billion in 2024 and is projected to surpass around USD 186.17 billion by 2034, expanding at a CAGR of 17.7% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Population Health Management Market, by Product Type, 2024-2034
7.1.1. Services
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Software
7.1.2.1. Market Revenue and Forecast (2021-2034)
8.1. Population Health Management Market, by Application, 2024-2034
8.1.1. Providers
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Payers
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Employer Group
8.1.3.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.2. Market Revenue and Forecast, by Application (2021-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.6.2. Market Revenue and Forecast, by Application (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.6.2. Market Revenue and Forecast, by Application (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.4.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.6.2. Market Revenue and Forecast, by Application (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.2. Market Revenue and Forecast, by Application (2021-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.3.2. Market Revenue and Forecast, by Application (2021-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.4.2. Market Revenue and Forecast, by Application (2021-2034)
10.1. Cerner Corporation
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Allscripts Healthcare, LLC
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Conifer Health Solutions, LLC
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Enli Health Intelligence
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. eClinicalWorks
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. McKesson Corporation
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Optum, Inc.
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Medecision
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Advisory Board
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Athenahealth, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Koninklijke Philips N.V.
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
10.12. Welltok
10.12.1. Company Overview
10.12.2. Product Offerings
10.12.3. Financial Performance
10.12.4. Recent Initiatives
10.13. RedBrick Health Corporation
10.13.1. Company Overview
10.13.2. Product Offerings
10.13.3. Financial Performance
10.13.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client